Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007801
Filing Date
2025-05-15
Accepted
2025-05-15 07:00:28
Documents
80
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q elev-20250331x10q.htm   iXBRL 10-Q 1965859
2 EX-10.1 elev-20250331xex10d1.htm EX-10.1 48926
3 EX-31.1 elev-20250331xex31d1.htm EX-31.1 15478
4 EX-31.2 elev-20250331xex31d2.htm EX-31.2 15450
5 EX-32 elev-20250331xex32.htm EX-32 8072
  Complete submission text file 0001558370-25-007801.txt   8343806

Data Files

Seq Description Document Type Size
6 EX-101.SCH elev-20250331.xsd EX-101.SCH 54638
7 EX-101.CAL elev-20250331_cal.xml EX-101.CAL 42114
8 EX-101.DEF elev-20250331_def.xml EX-101.DEF 232556
9 EX-101.LAB elev-20250331_lab.xml EX-101.LAB 503938
10 EX-101.PRE elev-20250331_pre.xml EX-101.PRE 397947
83 EXTRACTED XBRL INSTANCE DOCUMENT elev-20250331x10q_htm.xml XML 1357028
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

EIN.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40523 | Film No.: 25948623
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)